High density lipoprotein landmark trials

Jump to: navigation, search

High Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low HDL
High HDL

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

HDL Laboratory Test

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Clinical Trials

Landmark Trials

List of All Trials

Case Studies

Case #1

High density lipoprotein landmark trials On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High density lipoprotein landmark trials

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High density lipoprotein landmark trials

CDC on High density lipoprotein landmark trials

High density lipoprotein landmark trials in the news

Blogs on High density lipoprotein landmark trials

Directions to Hospitals Treating High density lipoprotein

Risk calculators and risk factors for High density lipoprotein landmark trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Reconstituted HDL Infusion

The CHI SQUARE Trial
A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers
Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers
CSL-112 Trial - Phase 2a
ERASE Trial
Infusion of Apo A-1 Milano

CETP Inhibitors

ACCELERATE Trial
Dal-OUTCOMES Trial
Dal-VESSEL Trial
Dal-PLAQUE Trial
DEFINE Trial
ILLUMINATE Trial
ILLUSTRATE Trial
REVEAL Trial
REVEAL HPS-3 TIMI-55 trial
RADIANCE 1
RADIANCE 2

Niacin

AIM-HIGH Trial
ARBITER 2 Trial
ARBITER 3 Trial
ARBITER 6-HALTS Trial
CLAS Trial
HATS Trial
Oxford Niaspan Study
Coronary Drug Project
Stockholm Ischemic Heart Disease Study
FATS
UCSF-SCOR

Fibrate

VA-HIT Trial
BECAIT Trial
BIP Trial
Helsinki Heart Study
DAIS
FIELD

Statin

ASTEROID Trial
SATURN Trial
4S Trial
CORONA Trial

Multiple Lipid Lowering Drugs

HARP Study
AFREGS Trial

Linked-in.jpg